Building tolerance gradually Your skin's ability to tolerate active ingredients increases with exposure
ARA290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic pain in spontaneous type 2 diabetes
Beyond Weight Loss: Peptides That Redefine Metabolic Health While GLP-1s have captured mainstream attention, the range of clinically relevant peptides extends much further
Science-based, highly effective daily flavonoid support.*
There is insufficient evidence to suggest that nucleoside analogs used in the treatment of HIV infection (i.e., zidovudine [AZT], didanosine [ddI], zalcitabine [ddC], and stavudine [d4T] or certain cancer chemotherapy agents (i.e., ifosfamide, cisplatin) increase the risk of secondary L-carnitine deficiency (135)